In Buprenorphine Therapy of Opiate Addiction, participating physicians
and toxicologists summarize and evaluate their experiences with five
years of intensive buprenorphine therapy. They cover all aspects of its
use, including the pharmacology, conditions of delivery, risks from use
with other psychoactive drugs, toxicology and related deaths, as well as
its testing in blood, urine, tissue, and hair. Special attention is
given to comparing the long-term care of opiate-dependent patients using
high-dose buprenorphine vs methadone, and to explaining the differences
in treatment, administration, and delivery. The authors also describe
how buprenorphine is currently prescribed and monitored in France and
Australia, and review all the latest advances in analytical techniques
for the determination of buprenorphine and its metabolites in biological
fluids and tissues.